810209X

C6-NBD Ceramide

Avanti Research^™ - A Croda Brand 810209X

• 同義詞: N-[6-[(7-nitro-2-1,3-benzoxadiazol-4-yl)amino]hexanoyl]-D-erythro-sphingosine:methanol (8:2)
• 經驗公式（希爾表示法）: C₃₀H₄₉N₅O₆
• CAS號碼: 94885-02-6
• 分子量：: 575.74
• 分類程式碼代碼: 12352211
• NACRES: NA.25

屬性

• 化驗: >99% (TLC)
• 形狀: liquid
• 包裝: pkg of 1 × 1 mL (810209X-1mg)
• 製造商／商標名: Avanti Research^™ - A Croda Brand 810209X
• 濃度: 1 mg/mL (810209X-1mg)
• 運輸包裝: dry ice
• 儲存溫度: −20°C
• InChI: 1S/C30H49N5O6/c1-2-3-4-5-6-7-8-9-10-11-12-13-15-18-27(37)25(23-36)32-28(38)19-16-14-17-22-31-24-20-21-26(35(39)40)30-29(24)33-41-34-30/h15,18,20-21,25,27,31,36-37H,2-14,16-17,19,22-23H2,1H3,(H,32,38)/b18-15+/t25-,27+/m0/s1
• InChI 密鑰: HZIRBXILQRLFIK-VPZZKNKNSA-N

描述

一般說明

C6-NBD ceramide is a fluorescent labelled compound, known to be useful for the detection of enzymatic action. C6-NBD ceramide is preferred over radioactive compounds.

應用

C6-NBD Ceramide is suitable as a substrate for sphingomyelin synthase activity assay.

生化／生理作用

Sphingolipid metabolism yields ceramide as one of the products. The family of ceramide synthases catalyses its synthesis. The ceramides differ in its acyl chain length. Ceramides possess a wide range of functions, associated with apoptosis, cancer inhibition and chemotherapy. Its action is also related to neurodegenerative diseases.

包裝

5 mL Amber Glass Screw Cap Vial (810209X-1mg)

法律資訊

Avanti Research is a trademark of Avanti Polar Lipids, LLC

安全資訊

• 象形圖: GHS02,GHS06,GHS08
• 訊號詞: Danger
• 危險聲明: H225,H302 + H312,H315,H319,H331,H336,H351,H361d,H370,H372
• 防範說明: P210 - P280 - P301 + P312 - P303 + P361 + P353 - P304 + P340 + P311 - P308 + P311
• 危險分類: Acute Tox. 3 Inhalation - Acute Tox. 4 Dermal - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Flam. Liq. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 Oral - STOT SE 1 - STOT SE 3
• 標靶器官: Central nervous system, Eyes,Central nervous system, Liver,Kidney
• 儲存類別代碼: 3 - Flammable liquids
• 水污染物質分類（WGK）: WGK 3